Drug Patents owned by Meridian Medcl

1. Drug name - ALSUMA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7811254 MERIDIAN MEDCL Autoinjector with needle depth adapter Aug, 2027

(4 years from now)

Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient

Treatment: Acute treatment of migraine attacks, with or without aura, and the treatment of cluster headache episodes

Dosage: INJECTABLE;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) INJECTABLE;SUBCUTANEOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.